~~<i id='CCD0A01DD1'><strike id='CCD0A01DD1'><tt id='CCD0A01DD1'><pre id='CCD0A01DD1'></pre></tt></strike></i>~~

Home» leisure time» leisure time

leisure time

author：explore 2025-09-29 03:43:13 Page View：2532

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： STAT Health News: Apple Watch import ban, Pfizer fumbles, etc
Next article： New air purifier tech could be key to improving indoor air quality

explore

At least 13 dead in Texas as scorching temps continue

1:17FirefighterEMTWilliamDorseyandfirefighterEMTRodrigoPinedatreatamigrantwomansufferingfromheatexha

Hospitals owned by private equity see complications spike 25%

AdobeThere’sampleevidencethatprivateequitybuyoutsinhealthcaredriveupcosts.Anewstudyshowsqualitydecli

Trump demands the U.S. pay no more for drugs than other countries … again

EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

How to keep neuroscience’s past racism from being its future

De-ShaineMurrayisworkingatthecuttingedgeofneurotechnology.AsapostdoctoralfellowatYale,heisdeveloping

WSS

leisure time

leisure time

knowledge

explore

How to keep neuroscience’s past racism from being its future